Compare BRNS & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRNS | CRT |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | United States | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 59.8M |
| IPO Year | 2021 | N/A |
| Metric | BRNS | CRT |
|---|---|---|
| Price | $0.55 | $10.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 33.5K | ★ 53.4K |
| Earning Date | 03-13-2026 | 03-12-2026 |
| Dividend Yield | N/A | ★ 6.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $7.07 |
| 52 Week High | $2.91 | $13.31 |
| Indicator | BRNS | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 35.70 | 68.31 |
| Support Level | N/A | $9.47 |
| Resistance Level | $0.76 | N/A |
| Average True Range (ATR) | 0.04 | 0.41 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 16.67 | 91.34 |
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.